Erik Rocheford joined Perspective as a Director in 2020, specializing in biopharma R&D executive and mid-market search. Prior to joining Perspective Erik spent five years at Stratacuity, where he successfully partnered with many venture-backed and early stage biotech companies to build their discovery, preclinical and broader scientific teams; ultimately leading all business development efforts for the firm. Prior to recruiting, Erik began his career as an in vivo pharmacologist at Novartis Institutes of Biomedical Research, where he led early discovery efforts in the cardiovascular and metabolism disease area, with a core focus on a range of targets, method development and lead candidate selection. Following NIBR, Erik joined Charles River Labs as a Study Director in its Discovery Services group. There, Erik led a team of scientists conducting early pharmacology screening and mechanism of action work for venture-backed and early stage biotech clients nationally. Erik’s scientific training and experience enables him to delve deeply into each client’s scientific and strategic objectives, and match these needs with the appropriate top talent. Erik’s breadth of recruiting experience with venture-backed and early stage companies enables him to provide clients with current market intelligence to inform each critical hire.
Erik received his B.S in Exercise Science from Colby-Sawyer College and his M.S. in Exercise Physiology from Colorado State University.